New (anecdotal) paper below [1].
Chronic Treatment of an Advanced Prostate-cancer Patient With Oral Methioninase Resulted in Long-term Stabilization of Rapidly Rising PSA Levels
I wrote about methionine restriction 2 years ago. [2]
"Our laboratory discovered methionine addiction, presumably a characteristic of all cancer types, including prostate cancer, which can be targeted by methionine restriction (MR), through treatment with oral recombinant methioninase (o-rMETase)."
"Before treatment, the patient had a rapid rise in PSA levels, from 39 to 56 ng/ml, within 6 weeks. At the 15th week of o-rMETase administration, the PSA levels stabilized at 62 ng/ml. No overt side effects were observed."
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/341...
In Vivo
. Jul-Aug 2021;35(4):2171-2176. doi: 10.21873/invivo.12488.
Chronic Treatment of an Advanced Prostate-cancer Patient With Oral Methioninase Resulted in Long-term Stabilization of Rapidly Rising PSA Levels
Qinghong Han 1 , Robert M Hoffman 2
Affiliations collapse
Affiliations
1 AntiCancer, Inc, San Diego, CA, U.S.A.
2 AntiCancer, Inc, San Diego, CA, U.S.A. all@anticancer.com.
PMID: 34182494 DOI: 10.21873/invivo.12488
Abstract
Background/aim: Advanced prostate cancer is a recalcitrant disease with very limited treatment options. Our laboratory discovered methionine addiction, presumably a characteristic of all cancer types, including prostate cancer, which can be targeted by methionine restriction (MR), through treatment with oral recombinant methioninase (o-rMETase).
Patients and methods: o-rMETase was produced by fermentation of recombinant E. coli containing the Pseudomonas putida methioninase gene, and purified by column chromatography. An advanced prostate cancer patient received o-rMETase as a supplement, 500 units per day, divided into two oral doses of 250 units each.
Results: Before treatment, the patient had a rapid rise in PSA levels, from 39 to 56 ng/ml, within 6 weeks. At the 15th week of o-rMETase administration, the PSA levels stabilized at 62 ng/ml. No overt side effects were observed.
Conclusion: o-rMETase single treatment can be beneficial for advanced prostate cancer patients.
Keywords: Methioninase; PSA; advanced prostate-cancer patient; methionine addiction; oral.
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.